Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis

참고문헌 (185)

1. Sung, H., "Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA, 71, pp.209~249 (2021)
2. Wong, M. C. S., "Global incidence and mortality of gastric cancer, 1980–2018", JAMA Netw. Open, 4, pp.e2118457~ (2021)
3. Cervantes, A., "Current questions for the treatment of advanced gastric cancer", Cancer Treat. Rev, 39, pp.60~67 (2013)
4. Tan, P., "Genetics and molecular pathogenesis of gastric adenocarcinoma", Gastroenterology, 149, pp.1153~1162 (2015)
5. Cancer Genome Atlas Research, N., "Comprehensive molecular characterization of gastric adenocarcinoma", Nature, 513, pp.202~209 (2014)
6. Padmanabhan, N., "How to stomach an epigenetic insult : the gastric cancer epigenome", Nat. Rev. Gastroenterol. Hepatol, 14, pp.467~478 (2017)
7. Yoda, Y., "Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer", Gastric Cancer, 18, pp.65~76 (2015)
8. Yamashita, S., "Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues", Proc. Natl Acad. Sci. USA, 115, pp.1328~1333 (2018)
9. Parsonnet, J., "Helicobacter pylori infection and the risk of gastric carcinoma", N. Engl. J. Med, 325, pp.1127~1131 (1991)
10. Nomura, A., "Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii", N. Engl. J. Med, 325, pp.1132~1136 (1991)
11. Uemura, N., "Helicobacter pylori infection and the development of gastric cancer", N. Engl. J. Med, 345, pp.784~789 (2001)
12. 배종면, "Epstein-Barr Virus and Gastric Cancer Risk: A Meta- analysis With Meta-regression of Case-control Studies", 예방의학회지, 49(2), pp.97~107 (2016), 대한예방의학회
13. Tavakoli, A., "Association between Epstein-Barr virus infection and gastric cancer : a systematic review and meta-analysis", BMC Cancer, 20, pp.493~ (2020)
14. Li, Y., "Hypermethylation in gastric cancer", Clin. Chim. Acta, 448, pp.124~132 (2015)
15. Matsusaka, K., "DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus", World J. Gastroenterol, 20, pp.3916~3926 (2014)
16. Fu, D. G., "Epigenetic alterations in gastric cancer(Review)", Mol. Med. Rep, 12, pp.3223~3230 (2015)
17. Kang, C, "Epigenetics: an emerging player in gastric cancer", World J. Gastroenterol, 20, pp.6433~6447 (2014)
18. Patel, T. N., "Gastric cancer and related epigenetic alterations", Ecancermedicalscience, 11, pp.714~ (2017)
19. Jenuwein, T., "Translating the histone code", Science, 293, pp.1074~1080 (2001)
20. 현광범, "Writing, erasing and reading histone lysine methylations", Experimental and Molecular Medicine, 49, pp.1~22 (2017), 생화학분자생물학회
21. Bannister, A. J., "Regulation of chromatin by histone modifications", Cell Res, 21, pp.381~395 (2011)
22. Ernst, J., "Mapping and analysis of chromatin state dynamics in nine human cell types", Nature, 473, pp.43~49 (2011)
23. Barski, A., "High-resolution profiling of histone methylations in the human genome", Cell, 129, pp.823~837 (2007)
24. Clapier, C. R., "Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes", Nat. Rev. Mol. Cell Biol, 18, pp.407~422 (2017)
25. Hota, S. K., "ATP-dependent chromatin remodeling during mammalian development", Development, 143, pp.2882~2897 (2016)
26. Calcagno, D. Q., "DNA and histone methylation in gastric carcinogenesis", World J. Gastroenterol, 19, pp.1182~1192 (2013)
27. Tie, J., "Epigenetic roles in the malignant transformation of gastric mucosal cells", Cell. Mol. Life Sci, 73, pp.4599~4610 (2016)
28. Meng, X., "Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer", Exp. Ther. Med, 18, pp.2219~2230 (2019)
29. Reyes, D. A., "Histone methyltransferases useful in gastric cancer research", Cancer Inf, 20, pp.11769351211039862~ (2021)
30. Chen, P., "Increased expression of EHMT2 associated with H3K9me2 level contributes to the poor prognosis of gastric cancer", Oncol. Lett, 20, pp.1734~1742 (2020)
31. Yin, C., "G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR", FASEB J, 33, pp.14036~14050 (2019)
32. He, L. J., "Prognostic significance of overexpression of EZH2 and H3k27me3proteins in gastric cancer", Asian Pac. J. Cancer Prev, 13, pp.3173~3178 (2012)
33. Xing, M., "Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer", J. Clin. Investig, 130, pp.3005~3020 (2020)
34. Gan, L., "The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter", J. Hematol. Oncol, 11, pp.9~ (2018)
35. Xu, J., "EZH2 promotes gastric cancer cells proliferation by repressing p21expression", Pathol. Res. Pract, 215, pp.152374~ (2019)
36. Huang, B., "Inhibition of EZH2 and activation of ERRgamma synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway", Gastric Cancer, 24, pp.72~84 (2021)
37. Sun, W., "Up-regulated WDR5 promotes gastric cancer formation by induced cyclin D1 expression", J. Cell. Biochem, 119, pp.3304~3316 (2018)
38. Wang, J., "Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer", Oncogene, 40, pp.4894~4905 (2021)
39. Wu, J., "Histone methyltransferase SETD1A induces epithelial-mesenchymal transition to promote invasion and metastasis through epigenetic reprogramming of snail in gastric cancer", Front. Cell Dev. Biol, 9, pp.657888~ (2021)
40. Song, Z., "The role of DOT1L in the proliferation and prognosis of gastric cancer", Biosci. Rep, 40, pp.BSR20193515~ (2020)
41. Okuno, K., "Asymmetric dimethylation at histone H3 arginine 2 by PRMT6 in gastric cancer progression", Carcinogenesis, 40, pp.15~26 (2019)
42. Liu, M., "PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression", Theranostics, 10, pp.4437~4452 (2020)
43. Zhao, L. J., "LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9", Pharmacol. Res, 159, pp.104991~ (2020)
44. Zhang, J., "Upregulation of LSD1 promotes migration and invasion in gastric cancer through facilitating EMT", Cancer Manag. Res, 11, pp.4481~4491 (2019)
45. Orenay-Boyacioglu, S., "Expression profiles of histone modification genes in gastric cancer progression", Mol. Biol. Rep, 45, pp.2275~2282 (2018)
46. Liu, X., "AURKA induces EMT by regulating histone modification through Wnt", beta-catenin and PI3K, Oncotarget, pp.2016, 7[DOI]
47. Yu, Y., "RBBP8", CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer, 2020, pp.39, 1273~1289
48. Wang, Y. M., "Histone acetyltransferase p300", CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines, 2017, pp.51, 1860~1868
49. Kim, M. S., "Genetic and expressional alterations of CHD genes in gastric and colorectal cancers", Histopathology, 58, pp.660~668 (2011)
50. Sawada, G., "CHD8 is an independent prognostic indicator that regulates Wnt", beta-catenin signaling and the cell cycle in gastric cancer, 2013, pp.30, 1137~1142
51. Hashimoto, T., "Clinical significance of chromatin remodeling factor CHD5expression in gastric cancer", Oncol. Lett, 19, pp.1066~1073 (2020)
52. Pontes, T. B., "Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis", Tumour Biol, 35, pp.3447~3453 (2014)
53. Toh, Y., "Overexpression of the MTA1 gene in gastrointestinal carcinomas : correlation with invasion and metastasis", Int. J. Cancer, 74, pp.459~463 (1997)
54. Lv, Z. Y., "Metastasis-associated protein 1(MTA1)in gastric cancer tissues is positively associated with poorer prognosis", Pathol. Res. Pract, 214, pp.536~541 (2018)
55. Zhou, C., "MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1", Mol. Cancer, 12, pp.102~ (2013)
56. Zhou, C., "MTA2 enhances colony formation and tumor growth of gastric cancer cells through IL-11", BMC Cancer, 15, pp.343~ (2015)
57. Dong, H., "The metastasis-associated gene MTA3, a component of the Mi-2", NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma, 2013, pp.8, e62986~
58. Wang, X., "SMARCB1-mediated SWI", SNF complex function is essential for enhancer regulation, 2017, pp.49, 289~295
59. Kassabov, S. R., "SWI", SNF unwraps, slides, and rewraps the nucleosome, 2003, pp.11, 391~403
60. Dechassa, M. L., "SWI", SNF has intrinsic nucleosome disassembly activity that is dependent on adjacent nucleosomes, 2010, pp.38, 590~602
61. Tsuruta, S., "Solid-type poorly differentiated adenocarcinoma of the stomach : deficiency of mismatch repair and SWI", SNF complex, 2020, pp.111, 1008~1019
62. Tessier-Cloutier, B., "Loss of switch", sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas, 2020, pp.77, 46~54
63. Gluckstein, M. I., "Comprehensive immunohistochemical study of the SWI", SNF complex expression status in gastric cancer reveals an adverse prognosis of SWI, Cancers(Basel), pp.2021, 13[DOI]
64. Liu, H., "High expression of SMARCE1predicts poor prognosis and promotes cell growth and metastasis in gastric cancer", Cancer Manag. Res, 11, pp.3493~3509 (2019)
65. Chandler, R. L., "ARID1a-DNA interactions are required for promoter occupancy by SWI", SNF, 2013, pp.33, 265~280
66. Wang, K., "Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer", Nat. Genet, 43, pp.1219~1223 (2011)
67. Zang, Z. J., "Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes", Nat. Genet, 44, pp.570~574 (2012)
68. Fabbrini, M. S., "1-Deoxymannojirimycin inhibits Golgi-mediated processing of glycoprotein in Xenopus oocytes", FEBS Lett, 234, pp.489~492 (1988)
69. Wiegand, K. C., "ARID1A", BAF250a as a prognostic marker for gastric carcinoma : a study of 2 cohorts, 2014, pp.45, 1258~1268
70. Han, N., "Loss of ARID1A expression is related to gastric cancer progression, Epstein-Barr virus infection, and mismatch repair deficiency", Appl. Immunohistochem. Mol. Morphol, 24, pp.320~325 (2016)
71. Nagl, N. G. Jr., "The p270(ARID1A", SMARCF1)subunit of mammalian SWI, Cancer Res, pp.2005, 65[DOI]
72. Zhang, Q., "Chromatin remodeling gene AT-rich interactive domaincontaining protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1", Oncotarget, 7, pp.46127~46141 (2016)
73. Dong, X., "Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting ARID1A deficiency", Gut, 71, pp.467~478 (2022)
74. Yan, H. B., "Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription", Carcinogenesis, 35, pp.867~876 (2014)
75. Loe, A. K. H., "Uncovering the dosage-dependent roles of Arid1a in gastric tumorigenesis for combinatorial drug therapy", J. Exp. Med, 218, pp.e20200219~ (2021)
76. Sentani, K., "Increased expression but not genetic alteration of BRG1, a component of the SWI", SNF complex, is associated with the advanced stage of human gastric carcinomas, 2001, pp.69, 315~320
77. Huang, L. Y., "SCF(FBW7)-mediated degradation of Brg1 suppresses gastric cancer metastasis", Nat. Commun, 9, pp.3569~ (2018)
78. Ailiken, G., "Post-transcriptional regulation of BRG1 by FIRDeltaexon2 in gastric cancer", Oncogenesis, 9, pp.26~ (2020)
79. Mathur, R., "ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice", Nat. Genet, 49, pp.296~302 (2017)
80. Alver, B. H., "The SWI", SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers, 2017, pp.8, 14648~
81. Nagl, N. G. Jr., "Distinct mammalian SWI", SNF chromatin remodeling complexes with opposing roles in cellcycle control, 2007, pp.26, 752~763
82. Ho, L., "esBAF facilitates pluripotency by conditioning the genome for LIF", STAT3 signalling and by regulating polycomb function, 2011, pp.13, 903~913
83. Wilson, B. G., "Epigenetic antagonism between polycomb and SWI", SNF complexes during oncogenic transformation, 2010, pp.18, 316~328
84. Bitler, B. G., "Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers", Nat. Med, 21, pp.231~238 (2015)
85. Yamada, L., "Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer", Gastric Cancer, 24, pp.60~71 (2021)
86. Hu, B. S., "High RSF-1 expression correlates with poor prognosis in patients with gastric adenocarcinoma", Int. J. Clin. Exp. Pathol, 5, pp.668~673 (2012)
87. Ding, L., "Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4", Mol. Cancer, 18, pp.45~ (2019)
88. Cai, Y., "YY1 functions with INO80 to activate transcription", Nat. Struct. Mol. Biol, 14, pp.872~874 (2007)
89. Wang, J., "The CCDC43–ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer", Cancer Lett, 482, pp.90~101 (2020)
90. Zhong, B. Z., "Effects of miR-384 and miR-134-5p acting on YY1 signaling transduction on biological function of gastric cancer cells", Onco Targets Ther, 13, pp.9631~9641 (2020)
91. Zheng, L., "miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1-facilitated MMP-14 expression", Sci. Rep, 7, pp.8967~ (2017)
92. Bhaskar Rao, D., "YY1 regulated transcription-based stratification of gastric tumors and identification of potential therapeutic candidates", J. Cell Commun. Signal, 15, pp.251~267 (2021)
93. Kang, W., "Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma", J. Transl. Med, 12, pp.80~ (2014)
94. Zhang, T., "YY1-modulated long non-coding RNA SNHG12 promotes gastric cancer metastasis by activating the miR-218-5p", YWHAZ axis, 2021, pp.17, 1629~1643
95. Muratani, M., "Nanoscale chromatin profiling of gastric adenocarcinoma reveals cancer-associated cryptic promoters and somatically acquired regulatory elements", Nat. Commun, 5, pp.4361~ (2014)
96. Qamra, A., "Epigenomic promoter alterations amplify gene isoform and immunogenic diversity in gastric adenocarcinoma", Cancer Discov, 7, pp.630~651 (2017)
97. Sundar, R., "Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition", Gut, 71, pp.1277~1288 (2022)
98. Demircioglu, D., "A pan-cancer transcriptome analysis reveals pervasive regulation through alternative promoters", Cell, 178, pp.1465~1477 (2019)
99. Huang, K. K., "Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer", Genome Biol, 22, pp.44~ (2021)
100. Ooi, W. F., "Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity", Nat. Commun, 7, pp.12983~ (2016)
101. Ooi, W. F., "Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma", Gut, 69, pp.1039~1052 (2020)
102. Maeda, M., "Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3", Gut, 69, pp.243~251 (2020)
103. Yasukawa, Y., "SAA1 is upregulated in gastric cancer-associated fibroblasts possibly by its enhancer activation", Carcinogenesis, 42, pp.180~189 (2021)
104. Macfarlane, L. A., "MicroRNA : biogenesis, function and role in cancer", Curr. Genom, 11, pp.537~561 (2010)
105. Yang, G., "LncRNA : a link between RNA and cancer", Biochim. Biophys. Acta, 1839, pp.1097~1109 (2014)
106. Zhang, X., "Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma", Oncotarget, 6, pp.32878~32889 (2015)
107. Hwang, J., "MicroRNA expression profiles in gastric carcinogenesis", Sci. Rep, 8, pp.14393~ (2018)
108. Zhang, H., "Integrated analysis of the miRNA, gene and pathway regulatory network in gastric cancer", Oncol. Rep, 35, pp.1135~1146 (2016)
109. Pereira, A., "miRNome reveals new insights into the molecular biology of field cancerization in gastric cancer", Front. Genet, 10, pp.592~ (2019)
110. Hu, M., "MicroRNAs and the PTEN", PI3K, Oncol. Rep, pp.2019, 41[DOI]
111. Wu, L., "MicroRNA-137 contributes to dampened tumorigenesis in human gastric cancer by targeting AKT2", PLoS ONE, 10, pp.e0130124~ (2015)
112. Chun-Zhi, Z., "MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN", BMC Cancer, 10, pp.367~ (2010)
113. Li, F., "Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1", FEBS Lett, 588, pp.538~544 (2014)
114. Wang, L., "miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4", Cancer Med, 8, pp.5264~5273 (2019)
115. Wang, Y. N., "MicroRNA-575 regulates development of gastric cancer by targeting PTEN", Biomed. Pharmacother, 113, pp.108716~ (2019)
116. Wang, Q., "microRNA-32-5p targets KLF2 to promote gastric cancer by activating PI3K", AKT signaling pathway, 2019, pp.11, 4895~4908
117. Streleckiene, G., "miR-20b and miR-451a are involved in gastric carcinogenesis through the PI3K", AKT, Int. J. Mol. Sci, pp.2020, 21[DOI]
118. Ashrafizadeh, M., "Wnt-regulating microRNAs role in gastric cancer malignancy", Life Sci, 250, pp.117547~ (2020)
119. Ooi, C. H., "Oncogenic pathway combinations predict clinical prognosis in gastric cancer", PLoS Genet, 5, pp.e1000676~ (2009)
120. Deng, S., "miRNA-192 and-215 activate Wnt", beta-catenin signaling pathway in gastric cancer via APC, 2020, pp.235, 6218~6229
121. Chen, J. Q., "MicroRNA-520f-3p inhibits proliferation of gastric cancer cells via targeting SOX9 and thereby inactivating Wnt signaling", Sci. Rep, 10, pp.6197~ (2020)
122. Li, T., "Molecular mechanisms of long noncoding RNAs on gastric cancer", Oncotarget, 7, pp.8601~8612 (2016)
123. Song, H., "Long non-coding RNA expression profile in human gastric cancer and its clinical significances", J. Transl. Med, 11, pp.225~ (2013)
124. Yang, F., "Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells", FEBS J, 279, pp.3159~3165 (2012)
125. Li, H., "Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer", Oncotarget, 5, pp.2318~2329 (2014)
126. Zhuang, M., "The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1", Biochem. Biophys. Res. Commun, 448, pp.315~322 (2014)
127. Liu, G., "Long noncoding RNA H19-derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells", Oncol. Res, 23, pp.99~107 (2016)
128. Zhou, X., "The interaction between MiR-141 and lncRNA-H19 in regulating cell proliferation and migration in gastric cancer", Cell. Physiol. Biochem, 36, pp.1440~1452 (2015)
129. Yu, J., "H19 rises in gastric cancer and exerts a tumor-promoting function via miR-138", E2F2 axis, 2020, pp.12, 13033~13042
130. Gan, L., "Long noncoding RNA H19 regulates cell growth and metastasis via the miR223p", Snail1 axis in gastric cancer, 2019, pp.54, 2157~2168
131. Wei, Z., "LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1", Gastric Cancer, 23, pp.1018~1032 (2020)
132. Xiao, J., "lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR-126 to active CXCR4 and RhoA signaling pathway", Cancer Med, 8, pp.6768~6779 (2019)
133. Xue, M., "HOTAIR induces the ubiquitination of Runx3 by interacting with Mex3b and enhances the invasion of gastric cancer cells", Gastric Cancer, 21, pp.756~764 (2018)
134. Zhang, J., "HOTAIR contributes to the carcinogenesis of gastric cancer via modulating cellular and exosomal miRNAs level", Cell Death Dis, 11, pp.780~ (2020)
135. Cao, W. J., "Analysis of long noncoding RNA expression profiles in gastric cancer", World J. Gastroenterol, 19, pp.3658~3664 (2013)
136. Esfandi, F., "Long noncoding RNAs expression in gastric cancer", J. Cell. Biochem, 120, pp.13802~13809 (2019)
137. Xu, M. D., "A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion", Clin. Cancer Res, 23, pp.2071~2080 (2017)
138. Niu, J., "Regulation of lncRNA PVT1 on miR-125 in metastasis of gastric cancer cells", Oncol. Lett, 19, pp.1261~1266 (2020)
139. Wang, L., "lncRNA PVT1 promotes the migration of gastric cancer by functioning as ceRNA of miR-30a and regulating Snail", J. Cell Physiol, 236, pp.536~548 (2021)
140. Wang, Y., "Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma", Mol. Genet. Genom, 289, pp.291~302 (2014)
141. Wang, J., "MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2", ASF, 2014, pp.68, 557~564
142. Shao, G., "Long non-coding RNA MALAT1 activates autophagy and promotes cell proliferation by downregulating microRNA-204 expression in gastric cancer", Oncol. Lett, 19, pp.805~812 (2020)
143. Zhu, K., "lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K", AKT pathway, 2019, pp.17, 5335~5342
144. Dai, Q., "LncRNA MALAT1 regulates the cell proliferation and cisplatin resistance in gastric cancer via PI3K", AKT pathway, 2020, pp.12, 1929~1939
145. Zhang, Y., "M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p", MLL3, J. Exp. Clin. Cancer Res, pp.2020, 39[DOI]
146. Ding, H., "MicroRNA-4513 promotes gastric cancer cell proliferation and epithelial–mesenchymal transition through targeting KAT6B", Hum. Gene Ther. Clin. Dev, 30, pp.142~148 (2019)
147. Bao, J., "miR-194 inhibits gastric cancer cell proliferation and tumorigenesis by targeting KDM5B", Eur. Rev. Med. Pharmacol. Sci, 20, pp.4487~4493 (2016)
148. Kong, Y., "RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A", Cancer Lett, 381, pp.138~148 (2016)
149. Cai, L., "MicroRNA-329 inhibits cell proliferation and tumor growth while facilitates apoptosis via negative regulation of KDM1A in gastric cancer", J. Cell. Biochem, 119, pp.3338~3351 (2018)
150. Zhang, J., "MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer", Am. J. Transl. Res, 10, pp.525~534 (2018)
151. Li, J., "miR-543 promotes gastric cancer cell proliferation by targeting SIRT1", Biochem. Biophys. Res. Commun, 469, pp.15~21 (2016)
152. Zhang, L., "MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells", BMC Cancer, 13, pp.290~ (2013)
153. Zhang, S., "Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a", Sci. Rep, 5, pp.9787~ (2015)
154. Song, H., "BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt", beta-catenin signaling, 2019, pp.852, 189~197
155. Lin, L., "Depletion of histone deacetylase 1 inhibits metastatic abilities of gastric cancer cells by regulating the miR-34a", CD44 pathway, 2015, pp.34, 663~672
156. Zhang, Z. Z., "Long non-coding RNA LINC00628 functions as a gastric cancer suppressor via long-range modulating the expression of cell cycle related genes", Sci. Rep, 6, pp.27435~ (2016)
157. Han, H., "Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2", Oncogene, 39, pp.6513~6528 (2020)
158. Xu, Q., "LINC00202 attenuates the progression of gastric cancer via suppressing expression level of KLF2", J. BUON, 26, pp.506~512 (2021)
159. Liu Jing, "LINC01232 Promotes Gastric Cancer Proliferation through Interacting with EZH2 to Inhibit the Transcription of KLF2", Journal of Microbiology and Biotechnology, 31(10), pp.1358~1365 (2021), 한국미생물·생명공학회[DOI]
160. Song, Y., "Long non-coding RNA HOTAIR mediates the switching of histone H3 lysine 27 acetylation to methylation to promote epithelial-to-mesenchymal transition in gastric cancer", Int. J. Oncol, 54, pp.77~86 (2019)
161. Zhu, L., "EZH2-mediated epigenetic suppression of lncRNA PCAT18 predicts a poor prognosis and regulates the expression of p16 by interacting with miR-570a-3p in gastric cancer", J. Cancer, 12, pp.7069~7078 (2021)
162. Shi, X., "Knockdown of LINC00461 inhibits cell proliferation and induces apoptosis in gastric cancer by targeting LSD1", Eur. Rev. Med. Pharmacol. Sci, 23, pp.10769~10775 (2019)
163. Lian, Y., "Long intergenic non-protein-coding RNA 01446 facilitates the proliferation and metastasis of gastric cancer cells through interacting with the histone lysine-specific demethylase LSD1", Cell Death Dis, 11, pp.522~ (2020)
164. Pan, Y., "LINC00675 suppresses cell proliferation and migration via downregulating the H3K4me2 level at the SPRY4 promoter in gastric cancer", Mol. Ther. Nucleic Acids, 22, pp.766~778 (2020)
165. Huang, M., "Long noncoding RNA LINC00673 is activated by SP1 and exerts oncogenic properties by interacting with LSD1 and EZH2 in gastric cancer", Mol. Ther, 25, pp.1014~1026 (2017)
166. Xu, T. P., "Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer", Oncogene, 37, pp.5020~5036 (2018)
167. Sun, T. T., "LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern", Cancer Discov, 6, pp.784~801 (2016)
168. Ma, M., "lncRNA GCAWKR promotes gastric cancer development by scaffolding the chromatin modification factors WDR5 and KAT2A", Mol. Ther, 26, pp.2658~2668 (2018)
169. Sun, M., "LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1", Cancer Res, 76, pp.6299~6310 (2016)
170. Ma, P., "KLF5-modulated lncRNA NEAT1 contributes to tumorigenesis by acting as a scaffold for BRG1 to silence GADD45A in gastric cancer", Mol. Ther. Nucleic Acids, 22, pp.382~395 (2020)
171. Okabe, A., "Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma", Nat. Genet, 52, pp.919~930 (2020)
172. Muhammad, J. S., "Helicobacter pylori-induced DNA methylation as an epigenetic modulator of gastric cancer : recent outcomes and future direction", Pathogens, 8, pp.23~ (2019)
173. Hayashi, Y., "CagA mediates epigenetic regulation to attenuate let-7expression in Helicobacter pylori-related carcinogenesis", Gut, 62, pp.1536~1546 (2013)
174. Yang, F., "NF-kappaB", miR-223-3p, Cell Death Dis, pp.2018, 9[DOI]
175. Shen, J., "Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis", Cancer Res, 75, pp.754~765 (2015)
176. 장훈, "Different MicroRNA Expression Levels in Gastric Cancer Depending on Helicobacter pylori Infection", Gut and Liver, 9(2), pp.188~196 (2015), 거트앤리버 소화기연관학회협의회
177. 이정원, "Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status", 대한암예방학회지, 22(1), pp.33~39 (2017), 대한암예방학회[DOI]
178. Matsushima, K., "MicroRNA signatures in Helicobacter pylori-infected gastric mucosa", Int. J. Cancer, 128, pp.361~370 (2011)
179. Zhu, H., "Microarray analysis of Long non-coding RNA expression profiles in human gastric cells and tissues with Helicobacter pylori infection", BMC Med. Genom, 8, pp.84~ (2015)
180. Chu, A., "Comprehensive analysis of aberrantly expressed ceRNA network in gastric cancer with and without H. pylori infection", J. Cancer, 10, pp.853~863 (2019)
181. Al-Lazikani, B., "Combinatorial drug therapy for cancer in the post-genomic era", Nat. Biotechnol, 30, pp.679~692 (2012)
182. Liu, S., "Diosgenin and GSK126 produce synergistic effects on epithelial–mesenchymal transition in gastric cancer cells by mediating EZH2 via the Rho", ROCK signaling pathway, 2020, pp.13, 5057~5067
183. Regel, I., "Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2", Gastroenterology, 143, pp.99~109 (2012)
184. 박종국, "Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells", Biomolecules & Therapeutics, 26(6), pp.591~598 (2018), 한국응용약물학회
185. Yoo, C., "Vorinostat in combination with capecitabine plus cisplatin as a firstline chemotherapy for patients with metastatic or unresectable gastric cancer : phase II study and biomarker analysis", Br. J. Cancer, 114, pp.1185~1190 (2016)

관련 논문AI추천